Deborah Mukherji· @dmukherji · X·· 23 小时前评分70
正文 · 原文
PROTEUS substudy results at #ESMO26
Perioperative apalutamide + ADT vs surgery alone in high-risk localized #ProstateCancer
EFS HR 0.38
MFS HR 0.49
Subsequent treatment at 3 years: 35% vs 68%
Compelling evidence for perioperative intensification @OncoAlert
165 浏览 · 6 赞 · 6 转发 · 1 回复
帖内回复
- Paul Sargos@PaulSargos
@dmukherji @OncoAlert Evidence? Which level?
来源：Deborah Mukherji · x.com